Pierre Fabre Boosts Cancer Drug Push in the Chinese Mainland
French firm Pierre Fabre Laboratories inked a deal with Sinopharm to commercialize anti-cancer drugs in the Chinese mainland, tapping into new opportunities ahead of China’s 15th Five-Year Plan.